Jeff "the illusive" Murray is an adviser on the Scientific board at Exavir Therapeutics... in their efforts to develop a long-acting antiviral for HIV...it appears to be animal studies at this point...They received $3 million in seed money from 3 investors...Gilead Sciences is in on the deal.